PATENT CLAIM ANALYSIS

Application Number: 16124013
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "200000"]

Abstract:
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate. Pharmaceutical compositions comprising the crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate are also disclosed.

Claim (Index 11):
The monohydrate of  claim 1 , which is substantially physically pure.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.42105
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849442', '15849324', '16124057', '16124066', '15849285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7996257255579386
- 35 USC 102 Novelty (BERT): 0.5382595559622929
- Combined Prediction Score: 0.773489108598374
- Mean Citation Score: 376.6563
- Max Citation Score: 399.31088
- Similarity Product: 252.33504620601653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test